BPC-157

BPC-157 is a synthetic peptide studied mainly in animals for tissue repair. In Australia it is not an approved medicine, is treated as prescription-only/compounded, and is banned in sport.

What it is

BPC-157 ("Body Protection Compound 157") is a synthetic chain of 15 amino acids (a "pentadecapeptide"). Its sequence is derived from a protein fragment originally identified in human gastric (stomach) juice. It does not occur naturally in the body as a standalone molecule — the marketed compound is laboratory-made. It is usually sold as a powder for reconstitution and injection, and sometimes in oral forms. It is most often discussed for soft-tissue and gut healing, but it is an experimental research compound, not an approved therapy.

How it works

The proposed mechanisms come almost entirely from laboratory and animal research, not from confirmed human biology. In those studies, BPC-157 is reported to promote the formation of new blood vessels (angiogenesis), support the survival and migration of fibroblasts (the cells that rebuild tendon and connective tissue), and interact with the nitric oxide system and certain growth-factor pathways. Researchers have also described effects on the gut lining in animal models. These are repeatedly observed effects in rodents, but how — or whether — they translate to the human body at any given dose is not established.

What the evidence says

The evidence for BPC-157 is overwhelmingly preclinical — from rats and laboratory experiments. A 2025 systematic review of BPC-157 for musculoskeletal injury identified roughly 35 preclinical studies but only a single clinical study. In animals, results for tendon, muscle, ligament and gut healing have been fairly consistent and positive. However, there are essentially no robust randomised controlled trials in humans, no confirmed effective human dose, and no long-term human safety data. Promising animal findings frequently fail to reproduce in people, so the honest summary is: interesting preclinical signal, unproven in humans.

Legal & regulatory status in Australia

BPC-157 is not included on the Australian Register of Therapeutic Goods (ARTG) — it is not an approved medicine and has not been assessed by the TGA for human use. It is handled as a prescription-only (Schedule 4) substance and is only accessed, if at all, via a doctor and a compounding pharmacy; it cannot be sold over the counter as a therapeutic good. The TGA has publicly raised concerns about unapproved "research" peptides marketed online. In sport, BPC-157 is prohibited at all times by WADA under category S0 (non-approved substances), and Sport Integrity Australia advises that a Therapeutic Use Exemption would not be granted.

Risks & considerations

Because there is little human data, the real risks are largely unknown rather than proven safe. Practical concerns include product quality and purity (grey-market peptides may be mislabelled, under-dosed or contaminated); incorrect reconstitution and injection (infection, injection-site reactions); unknown interactions with conditions or medications; and the theoretical concern that a compound promoting blood-vessel growth could have unwanted effects where abnormal tissue growth is undesirable. For athletes, use means an anti-doping violation.

What to ask a doctor

• Is there an approved, evidence-based treatment for my actual problem that I should try first?
• Given BPC-157 is unapproved and largely untested in humans, what are the realistic risks for me?
• If I am an athlete, how does this affect my anti-doping status?
• What does the lack of ARTG listing mean for product quality and my legal position?
• Are there interactions with my current medications or conditions?

FAQ

Q: Is BPC-157 approved as a medicine in Australia? A: No. It is not on the ARTG, has not been approved by the TGA for human use, and is treated as a prescription-only/compounded substance. Q: Does it actually work in humans? A: This is unproven. The supportive evidence is almost entirely from animal and lab studies; high-quality human trials are lacking. Q: Can athletes use it? A: No. It is banned at all times under WADA's S0 category, and Sport Integrity Australia indicates a Therapeutic Use Exemption would not be granted.